// App-Quantinova.ai

BSH2020‐EP‐103 : Lenalidomide with low‐dose dexamethasone in newly diagnosed transplant‐ineligible myeloma. Real‐world experience: Data from a Single Centre in North Wales, UK

Researchers

Presenter

  • C. Arachchilage

Principal Investigators

  • E. Heartin

  • C. Smith

Medical Centers

  • Hematology, Glan Clwyd Hospital, Rhyl, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved